Human Papillomavirus (HPV) Market, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Merck, GlaxoSmithKline, Roche, Pfizer and Others.

Human Papillomavirus (HPV) is the most common DNA virus that causes infection in the epithelial cells of skin and mucosa in which moist epithelial surfaces (squamous cells) include all areas covered by skin and/or mucosa such as the mouth interior, throat, tongue, tonsils, vagina, cervix, the urethra - the opening, and anus.
Contact of the above-mentioned areas with a virus leads to the transmission of the virus into, allowing it to transfer between epithelial cells. After establishment, sexual contacts, both conventional and oral becomes the means of transferring HPV through direct skin to skin contact. Other possible pathways for the transfer of virus is poorly known.

DelveInsight's "Human Papillomavirus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Human Papillomavirus (HPV), historical and forecasted epidemiology as well as the Human Papillomavirus (HPV) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Find a sample copy of the Human Papillomavirus Market report @ https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some Key HPV Market Facts:

1. The global HPV associated disorders market size was estimated at USD 16.34 billion in 2018.

2. According to DelveInsight, every day in the US, about 12,000 people of ages 15-24 are infected with HPV.

3. About 79 million Americans are currently infected with HPV and about 14 million people is likely to become newly infected each.

4. According to DelveInsight, every year, approximately 19,400 women and 12,100 men are affected by HPV causing cancers.

5. As per the Center for Disease Control and Prevention (CDC) (n.d.), males are found to be more prevalent than females for both oral and genital HPV.

6. As per a study titled "Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types," by Tanton et al. (2017), for all types, the prevalence was higher in the younger women (aged 16-20 and 21-24 years) than in those aged 25 or over.

Scope of Human Papillomavirus Market Report:

• The report covers the descriptive overview of Human Papillomavirus (HPV), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

• Comprehensive insight has been provided into the Human Papillomavirus (HPV) epidemiology and treatment in the 7MM

• Additionally, an all-inclusive account of both the current and emerging therapies for Human Papillomavirus (HPV) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

• A detailed review of Human Papillomavirus (HPV) market; historical and forecasted is included in the report, covering drug outreach in the 7MM

• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Human Papillomavirus (HPV) market

Request a sample and discover more about the report offerings @ https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

HPV can cause cervical and other cancers including cancer of the vagina, or anus. It can also cause cancer in the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer). Cancer often takes years, even decades, to develop after a person gets HPV. The types of HPV that can cause genital warts are not the same as the types of HPV that can cause cancers.

The percentages of cancers caused by oncogenic HPV are as follows:
• Anal cancer - 90%
• Vulvar cancer - 40%
• Vaginal cancer - 40%
• Oropharyngeal cancer - 12%
• Oral cancer - 3%

Find a sample copy of the Human Papillomavirus Market report @ https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the Key Human Papillomavirus Companies:
• Merck & Co.
• GlaxoSmithKline
• F. Hoffmann-La Roche
• Pfizer
• Allergan
• AstraZeneca
• Biocon Ltd.
• Eli Lilly and Company
• And Many Others

For further information on the Human Papillomavirus companies and their pipeline, reach out @ https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Human Papillomavirus Drugs Covered:
• Gardasil
• Ervarix
• VGX-3100
• ISA101
• VB10.16
• And Many Others

For further information on the Human Papillomavirus current pipeline therapeutics, reach out @ https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Human Papillomavirus (HPV)
3. Competitive Intelligence Analysis for Human Papillomavirus (HPV)
4. Human Papillomavirus (HPV): Market Overview at a Glance
5. Human Papillomavirus (HPV): Disease Background and Overview
6. Patient Journey
7. Human Papillomavirus (HPV) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Human Papillomavirus (HPV) Treatment
11. Marketed Products
12. Emerging Therapies
13. Human Papillomavirus (HPV): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Human Papillomavirus (HPV)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Request for HPV Sample Report @ https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.